Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex Grant US-11925676-B2 United States of America 12 Mar 2024
Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors… Grant US-11904016-B2 United States of America 20 Feb 2024
Method of treating cancer with composition comprising IL-15-based molecules and BCG Grant US-11890323-B2 United States of America 06 Feb 2024
Antibodies, combinations comprising antibodies, biomarkers, uses and methods Grant US-11779604-B2 United States of America 10 Oct 2023
Nucleic acids encoding anti-OX40L antibodies Grant US-11753479-B2 United States of America 12 Sep 2023
IL-15-based molecules and methods of use thereof Grant US-11679144-B2 United States of America 20 Jun 2023
Anti-tumor agent containing immunomodulator, and antitumor effect potentiator Grant US-11612653-B2 United States of America 28 Mar 2023
A Novel Combination of Trifluridine/Tipiracil Hydrochloride, an Antitumor Platinum Complex… Grant JP-7168575-B2 Japan 09 Nov 2022
IL-15-based molecules and methods of use thereof Grant US-11471511-B2 United States of America 18 Oct 2022
HIGH AFFINITY NEUTRALIZING MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1) AND… Application EP-3768719-A4 European Patent Office 27 Apr 2022
IL-15-based molecules and methods of use thereof Grant US-11173191-B2 United States of America 16 Nov 2021
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO… Application EP-3858859-A1 European Patent Office 04 Aug 2021
CCR5 INHIBITOR FOR USE IN TREATING CANCER Application US-20210205411-A1 United States of America 08 Jul 2021
ANTI-TUMOR AGENT CONTAINING IMMUNOMODULATOR AND ANTI-TUMOR EFFECT POTENTIATOR Grant AU-2017205531-B2 Australia 13 May 2021
Synergistic combination of immunologic inhibitors for the treatment of cancer Grant US-10967060-B2 United States of America 06 Apr 2021
COMPOSITIONS AND METHODS FOR TREATING EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) Application WO-2021043955-A1 World Intellectual Property Organisation (WIPO) 11 Mar 2021
High affinity neutralizing monoclonal antibodies to programmed death ligand 1(PD-L1) and… Application CN-111954682-A China 17 Nov 2020
USE OF SK2 INHIBITORS IN COMBINATION WITH IMMUNE CHECKPOINT BLOCKADE THERAPY FOR THE… Application WO-2020208060-A1 World Intellectual Property Organisation (WIPO) 15 Oct 2020
ANTI-TUMOR AGENT CONTAINING IMMUNOMODULATOR Application EP-3693019-A1 European Patent Office 12 Aug 2020
Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors… Grant US-10660954-B2 United States of America 26 May 2020
Method of treating cancer using immune checkpoint inhibitor Grant US-10544224-B2 United States of America 28 Jan 2020
ANTI-HUMAN PD-L1 HUMANIZED MONOCLONAL ANTIBODY AND APPLICATION THEREOF Application EP-3459973-A4 European Patent Office 25 Dec 2019
New combination between trifluridine/tipiracil hydrochloride, an anti-tumor platinum… Application TW-I671072-B Chinese Taipei 11 Sep 2019
ANTI-TUMOR AGENT CONTAINING IMMUNOMODULATOR, AND ANTI-TUMOR EFFECT ENHANCER Application EP-3400963-A4 European Patent Office 21 Aug 2019
SPECIFIC PD-L1 BINDING SEQUENCES INSERTED IN A CH3 DOMAIN Application WO-2019121906-A1 World Intellectual Property Organisation (WIPO) 27 Jun 2019
METHODS FOR TREATMENT AND SELECTION OF PATIENTS RESPONSIVE TO IMMUNE MEDIATED CANCER… Application EP-3387155-A4 European Patent Office 12 Jun 2019
COMBINATION BETWEEN TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, AN ANTI-TUMOR PLATINUM COMPLEX… Application WO-2018167256-A1 World Intellectual Property Organisation (WIPO) 20 Sep 2018
COMBINATION THERAPY FOR CANCER Application WO-2018029367-A1 World Intellectual Property Organisation (WIPO) 15 Feb 2018
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR Application WO-2017011666-A1 World Intellectual Property Organisation (WIPO) 19 Jan 2017